ALFA Finder| Revenue growth | FY26 revenue grew 2.1% YoY to ₹155,130 million. |
|---|---|
| Margins | Q4 EBITDA margin 15.3%; FY26 margin 12.8%, up 70bps. |
| Demand visibility | Strong CPG demand in Americas; soft demand in Europe. |
| Management confidence | High confidence in FY27 performance due to commissioned capacities. |
Growth
Q4 revenue rose 5.7% YoY to ₹40,973mn; EBITDA jumped 31.8% YoY. Full-year FY26 revenue grew 2.1% to ₹155,130mn.
Outlook
Projecting FY27 sales of 10-10.5bn aseptic packs. Significant capex capitalization of ₹1,900-2,000cr expected in FY27.
Risks
Supply chain disruptions from West Asia conflict and fluctuating raw material costs affecting packaging film spreads.
Last quarter's promises, checked
Delivered
- Guided FY26 EBITDA margin ~12% → delivered 12.8% (= BEAT)
- Guided FY26 EBITDA ₹1,800-1,850cr → delivered ₹1,985cr (= BEAT)
- Guided FY26 aseptic volume ~8.5bn packs → delivered 8.5bn packs (= BEAT)
Partly delivered
- Guided debt to peak at current levels (₹8,000cr net) → delivered improved leverage ratio but debt remains high (= PARTIAL)
Missed
- Guided top-line growth 5% → delivered 2.1% (= MISS)
Earnings Call filed with NSE, NSE: UFLEX. Summary written with AI assistance from the document.
Uflex Ltd: key numbers
- Share price
- ₹623.75
- Market cap
- ₹4,504 Cr
- Revenue (annual)
- ₹15,401 Cr
- Net profit (annual)
- ₹317.1 Cr
- P/E (TTM)
- 6.6×Sector 46.8×
- Promoter holding
- 44.58%+0.00% QoQ
- FII holding
- 9.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Uflex Ltd
All →Uflex Board Meeting Date
Uflex has scheduled a board meeting for 12-Nov-2026 to consider unaudited standalone and consolidated results for the quarter and half-year ended 30-Sep-2026. The trading window closed from 01-Oct-2026.
Uflex Annual General Meeting
Uflex shareholders approved a special resolution to borrow up to ₹5,000 Crore under Section 180(1)(c) via postal ballot, with 99.92% in favour. The result was declared on 31 October 2026.
Uflex Credit Rating
CRISIL Ratings has reaffirmed the credit ratings for Uflex Limited's total bank loan facilities of Rs. 4,600 Crore. The ratings remain unchanged for the company.
- Value
- ₹4,600 Cr
Uflex Credit Rating
Ind-Ra affirmed Uflex's bank loan facilities at IND AA-/Stable/IND A1+. The stable outlook unchanged signals continued creditworthiness of the company's debt structure.
Uflex Other Announcement
Uflex Limited has submitted the certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, for the quarter ended September 30, 2026, as received from its RTA.
Uflex Annual General Meeting
UFLEX Limited has issued a postal ballot notice seeking shareholder approval to increase the company's borrowing powers to a limit of Rs. 5,000 Crore.